Role of the TCR binding region of the HLA class I α2 domain in regulation of cell adhesion and proliferation

Journal of Immunology

Volumn 156, Issue 4, 1996, Pages 1415-1424

  Pettersen, Rolf D ^a   Hestdal, Kjetil ^a   Lie, Sverre O ^a   Gaudernack, Gustav ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL ADHESION; CELL AGGREGATION; CELL PROLIFERATION; GROWTH INHIBITION; HLA SYSTEM; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL;

ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BINDING SITES; CELL ADHESION; CELL AGGREGATION; CELLS, CULTURED; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA-A2 ANTIGEN; HUMANS; HYBRIDOMAS; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT PROTEINS; T-LYMPHOCYTES;

EID: 0030022145     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Bjorkman, P. J., M. A. Saper, B Samraoui, W. S. Bennett, J. L. Strominger, and D. C. Wiley. 1987. The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512.
2. Hedrick, S. M. 1988 Specificity of the T cell receptor for antigen. Adv. Immunol 43:193.
3. Davis, M. M., and P J Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature 334:395.
4. Yewdell, J. W , and J R Bennink 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes Adv. Immunol. 52.1.
5. Parnes, J. R 1989. Molecular biology and function of CD4 and CD8 Adv. Immunol. 44:265.
6. + T lymphocytes. J. Immunol. 148:1985
7. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
8. Arnaout, M. A. 1990 Structure and function of the leukocyte adhesion molecules CD11/CD18 Blood 75:1037.
9. Shimizu, Y., G A. van Seventer, K J. Morgan, and S. Shaw 1990. Roles of adhesion molecules in T-cell recognition: fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding, and costimulation. Immunol Rev 114:109.
10. Kansas, S G., J. C. Cambier, and T. F. Tedder. 1992. CD4 binding to major histocompatibility complex class II antigens induces LFA-1-dependent and independent homotypic adhesion of B lymphocytes. Eur J. Immunol. 22:147.
11. Nabavi, N., G. J. Freeman, A Gault, D. Godfrey, L. M. Nadler, and L. H Glimcher. 1992 Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression Nature 360 266.
12. Geppert, T. D., M C Wacholtz, L. S. Davies, and P. E. Lipsky. 1988. Activation of human T4 cells by cross-linking class I MKC molecules J. Immunol 140. 2155.
13. Houlden, B. A., S. M. Widacki, and J A. Bluestone. 1991. Signal transduction through class I MHC by a monoclonal antibody that detects multiple murine and human class I molecules. J. Immunol. 146:425.
14. Ødum, N., J. A Ledbetter, P. Martin, D. Geraghty, T. Tsu, J. A. Hansen, and P. Gladstone. 1991. Homotypic aggregation of human cell lines by HLA class II-, class Ia- and HLA-G specific monoclonal antibodies. Eur. J. Immunol 21:2121.
15. Alcover, A , V Juillard, and O. Acuto. 1992. Engagement of major histocompatibility complex class I and class II molecules up-regulates intercellular adhesion of human B cells via a CD11/CD18-independent mechanism Eur J. Immunol. 22:405.
16. Geppert, T D , H. Nguyen, and Lipsky P. E. 1992. Engagement of class I major histocompatibility complex molecules by cell surface CD8 delivers an activation signal. Eur. J. Immunol. 22:1379.
17. Turco, M. C., M De Felice, L Corbo, G. Morrone, R. Mertelsmann, S. Ferrone, and S. Venuta. 1985. Regulatory role of a monomorphic determinant of HLA class I antigens in T cell proliferation. J. Immunol. 135:2268.
18. Taylor, D. S., P. C. Nowell, and J. Kombluth. 1986. Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation Proc. Natl. Acad. Sci USA 83:4446.
19. Taylor D. S , P. C. Nowell, and J. Kornbluth. 1987 Anti-HLA class I antibodies inhibit the T cell-independent proliferation of human B lymphocytes. J. Immunol. 139:1792.
20. Dasgupta, J. D., K. Cemach, D. P. Dubey, E J. Yunis, and D. B. Amos 1987 The role of class I histocompatibility antigens in the regulation of T-cell activation. Proc. Natl Acad. Sci. USA 84:1094.
21. De Felice, M., M. C. Turco, P. C. Giarrusso, L. Corbo, R. Pizzano, V. Martinelli, S. Ferrone, and S. Venuta. 1987 Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation J. Immunol. 139:2683.
22. 3 domain of class I MHC. Science 252:1424.
23. Moots, R. J., M. Matsui, L. Pazmany, A. J. McMichael, and J. A. Frelinger. 1991 A cluster of mutations in HLA-A2 α2 helix abolishes peptide recognition by T cells. Immunogenetics 34:141.
24. Kägi, D., F. Vignaux, B. Ledermann, K. Bürki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994 Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528.
25. Berke, G. 1994. The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu. Rev. Immunol. 12:735.
26. Pettersen, R. D., K. Hestdal, N. Lee, D. E Geraghty, E. T Valø, S. O. Lie, and G. Gaudemack. 1995. RG1, a new murine monoclonal antibody recognizing a "supertypic" determinant on HLA-A molecules. Tissue Antigens 45:203.
27. Russo, C , A. K. Ng, M. A. Pellegrino, and S. Ferrone. 1983. The MoAb CR11-351 discriminates HLA-A2 variants identified by T cells. Immunogenetics 18:23.
28. Hogan, K. T., C Clayberger, E. I. Bernhard, S. F. Walk, J. P. Ridge, P. Parham, A. M. Krensky, and V. H. Engelhard. 1988. Identification by site-directed mutagenesis of amino acid residues contributing to serologic and CTL-defined epitope differences between HLA-A2.1 and HLA-A2.3. J. Immunol 141:2519.
29. Hogan, K. T., and Brown S L. 1992. Localization and characterization of serologic epitopes on HLA-A2. Hum. Immunol. 33:185.
30. McMichael, A. J., P. Parham, N. Rust, and F. Brodsky. 1980 A monoclonal antibody that recognizes an antigenic determinant shared by HLA-A2 and B17. Hum Immunol 1:121.
31. Santo-Aguado, J., J. A. Barbosa, P A Biro, and J L. Strominger. 1988. Molecular characterization of serologic recognition sites in the human HLA-A2 molecule. J Immunol. 141:2811.
32. Doménech, N., J. Santos-Aguado, and J. A. Lopez de Castro. 1991. Antigenicity of HLA-A2 and HLA-B7: loss and gain of serologic determinants induced by site-specific mutagenesis at residues 62 to 80. Hum. Immunol 30:140.
33. Parham, P., and W. F. Bodmer. 1978. Monoclonal antibody to a human histocompatibility alloantigen, HLA-A2 Nature 276:397
34. Salter, R. D , C. Clayberger, C. E. Lomen. A. M. Krensky, and P. Parham. 1987. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule. J. Exp. Med. 166:283.
35. Layet, C., B. Kahn-Perles, P. Pontarotti, P. Ferner, J. Sire, and F. A. Lemonnier 1987 Creation of an HLA-A2/HLA-Aw69 alloantigenic determinant on an HLA-A3 molecule by site-directed mutagenesis. J. Immunol. 138:2197.
36. Taketam, S., M. S. Krangel, D. Pious, and J. L. Strominger. 1983. Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1 further definition of an HLA-A2-specific serological determinant. J. Immunol. 131:2935.
37. Parham, P., and F. M. Brodsky. 1981. Partial purification and some properties of BB7 2: a cytotoxic monoclonal antibody with specificity for HLA-A2 and a vanant of HLA-A28. Hum Immunol 3:277
38. Grument, F. C., B. M. Fendly, L. Fish, S Foung, and E. G. Engleman 1982 Monoclonal antibody (B27 M2) subdividing HLA-B27. Hum. Immunol. 5:61.
39. Ways, J. P., and P. Parham. 1983. The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies J. Immunol. 131: 856.
40. Bodmer, J G , J. H. Moses, and S G. E. Marsh. 1992. Report on the monoclonal antibodies used in the Eleventh International Histocompatibility Workshop. In HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference Vol. 1. K Tsuji, M. Aizawa, and T. Sasazuki, eds Oxford Science Publications, New York, pp. 264.
41. Yang, S. Y., Y. Monshima, N. H. Collins, T. Alton, M. S. Pollack, E. J. Yunis, and B. Dupont. 1984. Comparison of one-dimensional IEF patterns for serologically detectable HLA-A and B allotypes. Immunogenetics 19:217.
42. Trapani, J. A., S. Mizuno, S. H. Kang, S. Y. Yang, and B. Dupont 1989 Molecular mapping of a new public HLA class I epitope shared by all HLA-B and HLA-C antigens and defined by a monoclonal antibody. Immunogenetics 29:25.
43. Zinszner, H., M. Masset, J F. Bourge, J. Colombani, D. Cohen, L. Degos, and P. Paul. 1990. Nucleotide sequence of the HLA-A26 class I gene: identification of specific residues and molecular mapping of public HLA class I epitopes. Hum. Immunol. 27.155.
44. Barnstable, C. J., W. F Bodmer, G. Brown, G. Galfre, C. Milstein, A. F. Williams, and A. Ziegler. 1978 Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens: new tools for genetic analysis. Cell 14:9.
45. Salter, R D., and P. Cresswell 1986. Impaired assembly and transport of HLA-A and -B antigens m a mutant TxB cell hybrid. EMBO J. 5:943.
46. Helgestad, J., R. Pettersen, I. Storm-Mathisen, L. Schjerven, K Ulrich, E B Smeland, T. Egeland, D Sørskaard, A. Brøgger, T Hovig, M Degré, and S O. Lie. 1990. Characterization of a new malignant human T-cell line (PFI-285) sensitive to ascorbic acid. Eur. J. Haematol. 44:9.
47. Gur, H., F. El-Zaatari, T D. Geppert, M. C Wacholtz, J D. Taurog, and P E. Lipsky. 1990. Analysis of T cell signaling by class I MHC molecules: the cytoptasmic domain is not required for signal transduction. J. Exp. Med. 172:1267.
48. Vandal, F , G Gaudernack, S. Funderud, A. Bratlie, T. Lea, J. Ugelstad, and E Thorsby. 1986 HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation: a fast and reliable technique. Tissue Antigens 28:301.
49. de Fougerolles, A R , S A Stacker. R. Schwarting, and T. A Springer. 1991. Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J. Exp. Med 174.253.
50. Linsley, P. S., W. Brady, L. Grosmaire, A. Aruffo, N. K. Damle, and J A Ledbetter. 1991. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and IL-2 mRNA accumulation. J. Exp. Med. 173:721.
51. Linsley, P. S., and J A. Ledbetter 1993. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev Immunol. 11:191.
52. Baroja, M L , K. Lorre, F. Van Vaeck, and J. L. Ceuppens 1989. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provider a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Cell. Immunol 120:205.
53. Williams, T M , D. M. Moolten, H. Makni, H. W. Kim, J. A. Kant, and M. Kamoun. 1992. CD28-stimulated IL-2 gene expression in Jurkat T cells occurs in part transcriptionally and is cyclosporine-A sensitive. J. Immunol. 148: 2609.
54. Sansom, D. M., A. Wilson, M Boshell, J Lewis, and N. D. Hall. 1993. B7/CD28 but not LFA-3/CD2 interactions can provide "third-party" co-stimulation for human T-cell activation Immunology 80:242.
55. Chen, C , A. Gault, L. Shen, and N. Nabavi. 1994. Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule. J. Immunol. 152:4929
56. Arstila, T. P., O. Vainio, and O. Lasslia. 1994. Evolutionary conserved function of CD28 in αβ T cell activation. Scand. J. Immunol. 40:368.
57. June, C. H., K. M Jackson, J. A. Ledbetter, J. M. Leiden, T. Lindsten, and C. B Thompson. 1989. Two distinct mechanisms of interleukin-2 gene expression in human T lymphocytes J. Autoimmun 2(Suppl):55.
58. Green, J. M., L. A. Turka, C. H. June, and C. B. Thompson. 1992. CD28 and staphylococcal enterotoxins synergize to induce MHC-independent T-cell proliferation Cell. Immunol. 145:11.
59. Ohnishi, H., T Tanaka, J. Takahara, and M. Kotb. 1993. CD28 delivers costimulatory signals for superantigen-induced activation of antigen-presenting celt-depleted human T lymphocytes J. Immunol. 150:3207
60. Ohnishi, H., J. A. Ledbetter, S. B. Kanner, P. S. Linsley, T. Tanaka, A. M. Geller, and M. Kotb 1995. CD28 cross-linking augments TCR-mediated signals and costimulates superantigen responses. J. Immunol. 154:3180.
61. Alderson, M R., R. J Armitage, E Maraskovsky, T. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med 178:2231.
62. Wade, W. F., J. Davoust, J. Salamero, P. André. T. H. Watts, and J. C. Cambier 1993. Structural compartmentalization of MHC class II signaling function. Immunol. Today 14:539.
63. + T cells is regulated by the antigen-presenting cell. J. Immunol. 150:3832
64. Grassi, F., R. Meneveri, M. Gullberg, L. Lopalco, G. B. Rossi, P Lanza, C. De Santis, G. Brattsand, S. Butto, E. Ginelli, A. Beretta, and A. G Siccardi 1991. Human immunodeficiency virus type 1 gp120 mimics a hidden monomorphic epitope borne by class I major histocompatibility complex heavy chains. J. Exp. Med. 174:53.
65. Thompson, C. B., T. Lindsten, J. A. Ledbetter, S. L. Kunkel, H. A. Young, S. G. Emerson, J M. Leiden, and C. H June. 1989. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc. Natl. Acad. Sci USA 86:1333.
66. June, C. H., J. A. Bluestone, L M. Nadler, and C. B. Thompson. 1994. The B7 and CD28 receptor families. Immunol Today 15:321.
67. Cerdan, C. C., Y. Martin, M Courcoul, C. Mawas, F Birg, and D. Olive 1995. CD28 costimulation up-regulates long-term IL-2Rβ expression in human T cells through combined transcriptional and post-transcriptional regulation. J. Immunol 154:1007.
68. Moss, D J , S. R. Burrows, G D. Baxter, and M. F. Lavin. 1991. T cell-T cell killing is induced by specific epitopes' evidence for an apoptotic mechanism. J. Exp. Med. 173.681.
69. 9 FEBS Lett. 333:211.
70. Silvestris, F., R. C. Williams, Jr, and F. Dammacco. 1995. Autoreactivity in HIV-1 infection, the role of molecular mimicry. Clin. Immunol. Immunopathol. 75:197.
71. De Santis, C., P. Robbioni, R. Longhi, L. Lopalco, A G. Siccardi, A. Beretta, and N J. Roberts, Jr. 1993. Cross-reactive response to human immunodeficiency virus type t (HTV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1-derived envelope vaccines. J. Infect. Dis. 168:1396.
72. + T lymphocytes during HIV-1 infection. J. Acquired Immune Defic. Syndr. 7:245.
73. Borthwick, N J., M. Bofill, W. M. Gombert, A. N Akbar, E Medina, K. Sagawa, M. C. Lipman, M. A. Johnson, and G. Janossy. 1994. Lymphocyte activation m HIV-1 infection. II. Functional defects of CD28 T cells. AIDS 8:431.
74. Gimini, C. D., G. J. Freeman, J. G. Gribben, G. Gray, and L. M. Nadler. 1993. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl Acad. Sci. USA 90:6586.
75. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175.331.